We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01377896
First Posted: June 22, 2011
Last Update Posted: June 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
  Purpose
'Real life' retrospective patient cases (10) to provide an objective and robust analytical report of patient management and prescriptions behaviours for Schizophrenia, Bipolar disorders and Major depressive disorders.

Condition
Schizophrenia Bipolar Disorders Major Depressive Disorders

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Enrollment: 221
Study Start Date: July 2010
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with cardiovascular events
Criteria

Inclusion Criteria:

  • Patients diagnosed with one of the following conditions: Schizophrenia, Bipolar disorders and Major depressive disorders.

Exclusion Criteria:

  • Patients who have not been diagnosed with the conditions as outlined in the Inclusion criteria.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: MC MD, AstraZeneca
ClinicalTrials.gov Identifier: NCT01377896     History of Changes
Other Study ID Numbers: NIS-NZA-XXX-2011/1
First Submitted: June 14, 2011
First Posted: June 22, 2011
Last Update Posted: June 28, 2011
Last Verified: June 2011

Additional relevant MeSH terms:
Disease
Schizophrenia
Depressive Disorder
Depression
Depressive Disorder, Major
Bipolar Disorder
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
Mood Disorders
Behavioral Symptoms
Bipolar and Related Disorders